Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,885 | 205 | 59.3% |
| Travel and Lodging | $3,241 | 11 | 39.3% |
| Education | $111.10 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $2,994 | 19 | $0 (2020) |
| KARL STORZ Endoscopy-America | $1,139 | 5 | $0 (2018) |
| Astellas Pharma US Inc | $733.93 | 46 | $0 (2023) |
| PROCEPT BioRobotics Corporation | $616.64 | 7 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $318.60 | 11 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $299.41 | 17 | $0 (2024) |
| Boston Scientific Corporation | $200.00 | 9 | $0 (2024) |
| Calyxo, Inc. | $166.24 | 2 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $164.40 | 12 | $0 (2021) |
| AbbVie, Inc. | $149.20 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,050 | 23 | PROCEPT BioRobotics Corporation ($550.35) |
| 2023 | $595.19 | 19 | Myriad Genetic Laboratories, Inc. ($260.60) |
| 2022 | $133.83 | 8 | UroGen Pharma, Inc. ($27.39) |
| 2021 | $179.66 | 10 | Rochester Medical Corporation ($50.05) |
| 2020 | $1,723 | 19 | NeoTract Inc. ($1,601) |
| 2019 | $858.17 | 40 | Astellas Pharma US Inc ($324.73) |
| 2018 | $2,947 | 60 | KARL STORZ Endoscopy-America ($1,139) |
| 2017 | $750.44 | 41 | Astellas Pharma US Inc ($147.06) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $140.64 | General |
| Category: Urology | ||||||
| 10/22/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $85.30 | General |
| Category: UROLOGY | ||||||
| 09/19/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/18/2024 | Vertical Pharmaceuticals, LLC | DSUVIA (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Analgesics | ||||||
| 08/14/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 08/13/2024 | Cook Medical LLC | RESONANCE (Device) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Urology | ||||||
| 07/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2024 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $46.43 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 05/29/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2024 | COLOPLAST CORP | Coloplast TFL Drive (Device) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Endourology | ||||||
| 03/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $328.62 | General |
| Category: UROLOGY | ||||||
| 02/16/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $61.00 | General |
| Category: UROLOGY | ||||||
| 02/16/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $53.75 | General |
| Category: UROLOGY | ||||||
| 02/16/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $21.68 | General |
| Category: UROLOGY | ||||||
| 02/15/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: rezum_URO | ||||||
| 01/30/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Education | In-kind items and services | $13.19 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: HORMONE THERAPY | ||||||
| 12/20/2023 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Orthodontic Dentistry | ||||||
| 12/12/2023 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $20.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 4,144 | 12,947 | $1.6M | $329,566 |
| 2022 | 41 | 4,299 | 14,467 | $2.0M | $369,845 |
| 2021 | 43 | 4,234 | 13,395 | $1.4M | $322,205 |
| 2020 | 43 | 4,102 | 8,412 | $1.3M | $289,758 |
All Medicare Procedures & Services
172 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 702 | 1,028 | $295,067 | $65,610 | 22.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 203 | 238 | $175,889 | $40,441 | 23.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 29 | 194 | $114,084 | $26,373 | 23.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 156 | 310 | $69,599 | $19,291 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 195 | $79,176 | $18,090 | 22.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 146 | 153 | $65,032 | $15,800 | 24.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 177 | 190 | $66,506 | $14,314 | 21.5% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 29 | 6,700 | $67,192 | $14,012 | 20.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 285 | 317 | $55,389 | $12,202 | 22.0% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 32 | 148 | $41,740 | $9,662 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 131 | 131 | $46,509 | $9,591 | 20.6% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 16 | 16 | $86,352 | $8,783 | 10.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 19 | 23 | $30,913 | $7,307 | 23.6% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 28 | 30 | $29,761 | $7,254 | 24.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 74 | 143 | $17,164 | $5,632 | 32.8% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 15 | 22 | $20,505 | $4,783 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $21,201 | $4,499 | 21.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 24 | 24 | $19,081 | $4,231 | 22.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 989 | 1,890 | $28,407 | $4,136 | 14.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 407 | 539 | $32,356 | $4,125 | 12.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 33 | 39 | $54,640 | $3,949 | 7.2% |
| 76873 | Ultrasound scan of prostate through rectum | Office | 2023 | 28 | 28 | $15,345 | $3,723 | 24.3% |
| 51705 | Simple change of bladder tube | Office | 2023 | 12 | 53 | $16,379 | $3,542 | 21.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 27 | 29 | $12,471 | $2,936 | 23.5% |
| 52001 | Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | Facility | 2023 | 12 | 12 | $16,800 | $2,480 | 14.8% |
About Dr. Charles Cobb, MD
Dr. Charles Cobb, MD is a Urology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083752000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Cobb, MD has received a total of $8,237 in payments from pharmaceutical and medical device companies, with $1,050 received in 2024. These payments were reported across 220 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,885).
As a Medicare-enrolled provider, Cobb has provided services to 16,779 Medicare beneficiaries, totaling 49,221 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 172 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Jacksonville, FL
- Active Since 02/02/2007
- Last Updated 05/08/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1083752000
Products in Payments
- UroLift (Device) $1,939
- UROLIFT (Device) $978.76
- TRADE PROMO: SPIES FLEXC, US DEFL (Device) $972.27
- AQUABEAM SYSTEM (Device) $550.35
- XTANDI (Drug) $386.06
- PROLARIS (Device) $304.76
- MYRBETRIQ (Drug) $233.17
- Myrbetriq (Drug) $176.81
- CVAC ASPIRATION SYSTEM (Device) $166.24
- URETEROSCOPE, 7.5 FR. X 675 MM (Device) $144.40
- Urolift - UL400 (Device) $137.82
- FIRMAGON (Drug) $120.48
- Noctiva (Drug) $114.96
- Axonics (Device) $114.75
- ADSTILADRIN (Biological) $106.69
- Androgel (Drug) $100.59
- XIAFLEX (Biological) $99.21
- Erleada (Drug) $80.20
- ELIGARD (Drug) $71.00
- NOCDURNA (Drug) $68.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Jacksonville
Raymond Pak, Md, MD
Urology — Payments: $250,729
Douglas Swartz, Md, MD
Urology — Payments: $151,930
Sagar Shah, Md, MD
Urology — Payments: $80,104
Dr. Ali Kasraeian, Md, MD
Urology — Payments: $63,254
Dr. Bryce Baird, Md, MD
Urology — Payments: $54,548
Dr. Kethandapatti Balaji, Mbbs, MBBS
Urology — Payments: $32,493